Trial Profile
A open label, randomized, comparative study on efficacy, safety and reduction of diabetic complications, with regimens of metformin, glimeperide, & vildagliptin vs metformin, Glimeperide, & dapagliflozin in type – 2 diabetic patients.
Status:
Completed
Phase of Trial:
Phase III/IV
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Glimepiride; Metformin; Vildagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jan 2020 Status changed from not yet recruiting to completed.
- 30 May 2017 New trial record